In an adult trauma patient who requires rapid effective analgesia and has no contraindications to either drug, is intranasal ketamine or inhaled methoxyflurane the safer and more practical first‑line choice?

Intranasal Ketamine vs Inhaled Methoxyflurane for Trauma Patients

When intravenous access is available or can be readily established, ketamine (IV or intranasal) is the superior first-line analgesic for adult trauma patients because it provides faster, more reliable pain relief with better hemodynamic stability and a more robust evidence base than methoxyflurane. 1

Clinical Decision Algorithm

Step 1: Assess IV Access

• If IV access is present or easily obtainable → Use low-dose IV ketamine as first-line (0.15–0.30 mg/kg bolus followed by 1–2 µg/kg/min infusion) 1

  • This approach reduces opioid requirements by approximately 22 mg morphine equivalents and provides superior multimodal analgesia 2, 1
  • Respiratory depression occurs in only 0.05% of cases, making it safer than traditional opioids 1

• If IV access cannot be established after 1–2 attempts → Consider intranasal ketamine (0.5–0.75 mg/kg) as the preferred needle-free option 3, 4

  • Achieves clinically significant pain reduction (≥13 mm VAS decrease) in 88% of patients within median 9.5 minutes 4
  • 80% of patients achieve ≥20 mm VAS reduction at 15 minutes 3

• If intranasal route is contraindicated or unavailable → Use inhaled methoxyflurane (3 mL via handheld inhaler) 5

  • This is the only scenario where methoxyflurane becomes first-line 2

Step 2: Screen for Contraindications

Ketamine Absolute Contraindications:

• Uncontrolled hypertension (must be treated first) 1
• Active psychosis or severe psychiatric instability 1

Ketamine Relative Cautions:

• Uncontrolled cardiovascular disease → Consider methoxyflurane instead 1
• Risk of psychotomimetic effects → Prophylax with midazolam 0.05–0.10 mg/kg IV 1
• Increased airway secretions → Pretreat with atropine or glycopyrrolate 2, 1

Methoxyflurane Contraindications:

• Concurrent tetracycline antibiotics (minocycline, doxycycline) → Absolute contraindication due to drug interactions 1, 5
• Severe renal impairment → Use with extreme caution; elderly patients require renal function monitoring 5
• Concurrent CNS depressants → Risk of additive sedation 5

Step 3: Administer and Monitor

Ketamine Protocol (Preferred)

Route	Dose	Onset	Key Advantage
IV bolus	0.15–0.30 mg/kg (up to 0.5 mg/kg for severe pain) [1]	1–2 minutes	Fastest onset, titratable
IV infusion	1–2 µg/kg/min [1]	Continuous	Sustained analgesia
Intranasal	0.5–0.75 mg/kg [3,4]	5–10 minutes	No IV needed

Adjuncts:

• Add acetaminophen 1 g IV/PO every 6 hours for multimodal analgesia 1
• Consider midazolam 0.05–0.10 mg/kg IV to prevent emergence phenomena 1

Monitoring Requirements:

• Continuous cardiac monitoring, pulse oximetry, and serial sedation assessments 1

Methoxyflurane Protocol (Alternative)

Parameter	Details
Dose	3 mL via handheld inhaler, self-administered under supervision [1,5]
Onset	Variable (typically 5–15 minutes) [6]
Success rate	97% for procedural analgesia [6]
Monitoring	Level of consciousness, respiratory status, renal function (especially elderly) [5]

Evidence Hierarchy and Rationale

Why Ketamine is Superior

1. Stronger evidence base: Multiple high-quality RCTs demonstrate ketamine's efficacy for trauma analgesia, whereas methoxyflurane has limited data—primarily one RCT showing superiority to morphine for short-term pain relief 1

2. Hemodynamic stability: Ketamine's sympathomimetic effects maintain blood pressure and cardiac output, making it ideal for trauma patients who may be hypovolemic 2, 1

3. Bronchodilation benefit: In patients with asthma or COPD, ketamine improves airway tone—a critical advantage over methoxyflurane 2, 1

4. Multimodal synergy: Low-dose ketamine reduces opioid requirements and may prevent chronic pain development 2

When Methoxyflurane Has a Role

• Out-of-hospital settings without IV access: Methoxyflurane's self-administration capability makes it practical when IV ketamine is not feasible 2, 5
• Conscious, cooperative patients: The handheld inhaler requires patient cooperation 6
• Moderate-to-severe trauma pain: Guideline evidence confirms efficacy for this specific indication 2

Common Pitfalls to Avoid

1. Using methoxyflurane when IV access is available: This wastes the superior efficacy and safety profile of IV ketamine 1

2. Forgetting anticholinergic premedication: Ketamine increases airway secretions; atropine or glycopyrrolate prevents this complication 2, 1

3. Ignoring tetracycline interactions: Always screen medication lists before methoxyflurane administration 1, 5

4. Underdosing intranasal ketamine: Studies show 0.5–0.75 mg/kg is required for efficacy; lower doses fail 3, 4

5. Skipping benzodiazepine prophylaxis: Midazolam significantly reduces ketamine's dysphoric effects without compromising analgesia 1

Practical Implementation

For the typical trauma patient with IV access:

• Start with IV ketamine 0.15–0.30 mg/kg bolus 1
• Add acetaminophen 1 g IV 1
• Consider midazolam 0.05–0.10 mg/kg IV if psychotomimetic effects are a concern 1
• Transition to ketamine infusion 1–2 µg/kg/min for sustained analgesia 1

For the prehospital patient without IV access:

• Attempt intranasal ketamine 0.5–0.75 mg/kg first 3, 4
• Reserve methoxyflurane for cases where intranasal route fails or is contraindicated 2, 5